- Hooshmandi, Mehdi;
- Sharma, Vijendra;
- Thörn Perez, Carolina;
- Sood, Rapita;
- Krimbacher, Konstanze;
- Wong, Calvin;
- Lister, Kevin C;
- Ureña Guzmán, Alba;
- Bartley, Trevor D;
- Rocha, Cecilia;
- Maussion, Gilles;
- Nadler, Emma;
- Roque, Patricia Margarita;
- Gantois, Ilse;
- Popic, Jelena;
- Lévesque, Maxime;
- Kaufman, Randal J;
- Avoli, Massimo;
- Sanz, Elisenda;
- Nader, Karim;
- Hagerman, Randi Jenssen;
- Durcan, Thomas M;
- Costa-Mattioli, Mauro;
- Prager-Khoutorsky, Masha;
- Lacaille, Jean-Claude;
- Martinez-Cerdeno, Veronica;
- Gibson, Jay R;
- Huber, Kimberly M;
- Sonenberg, Nahum;
- Gkogkas, Christos G;
- Khoutorsky, Arkady
Dysregulation of protein synthesis is one of the key mechanisms underlying autism spectrum disorder (ASD). However, the role of a major pathway controlling protein synthesis, the integrated stress response (ISR), in ASD remains poorly understood. Here, we demonstrate that the main arm of the ISR, eIF2α phosphorylation (p-eIF2α), is suppressed in excitatory, but not inhibitory, neurons in a mouse model of fragile X syndrome (FXS; Fmr1-/y). We further show that the decrease in p-eIF2α is mediated via activation of mTORC1. Genetic reduction of p-eIF2α only in excitatory neurons is sufficient to increase general protein synthesis and cause autism-like behavior. In Fmr1-/y mice, restoration of p-eIF2α solely in excitatory neurons reverses elevated protein synthesis and rescues autism-related phenotypes. Thus, we reveal a previously unknown causal relationship between excitatory neuron-specific translational control via the ISR pathway, general protein synthesis, and core phenotypes reminiscent of autism in a mouse model of FXS.